Since we recently found in a cell culture model that activation of MNRR1 resolved the effect of LPS-induced inflammation [29], and that mitochondrial diseases are associated with a pro-inflammatory phenotype [30,31,32], we also asked if we could rescue the effects of LPS in these patient fibroblasts. Here, CHCHD2 is linked to mitochondrial disease.